Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 3' untranslated regions (UTRs) of cytoskeletal gene mRNAs are essential regulatory segments that govern the spatial and temporal expression of proteins like actin, tubulin, and vimentin. These regions contain specific sequence motifs, known as "zipcodes," which serve as binding sites for RNA-binding proteins (RBPs) that facilitate mRNA transport to distinct subcellular compartments, such as the leading edge of migrating cells or neuronal synapses (Hüttelmaier et al., 2005, Nature). By controlling where and when cytoskeletal proteins are synthesized, these 3' UTRs play a fundamental role in maintaining cell polarity, motility, and structural integrity. In pathological contexts, such as oncology, the loss of proper mRNA localization due to 3' UTR mutations or RBP dysregulation is a known driver of epithelial-to-mesenchymal transition and metastatic spread (Gu et al., 2012, J. Cell Biol.). Furthermore, impaired transport of cytoskeletal mRNAs in neurons is linked to synaptic dysfunction in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) (Bassell and Kelic, 2004, Genes Dev.). Although not currently targeted by approved pharmaceuticals, these regions represent a frontier for RNA-targeted therapies, including antisense oligonucleotides (ASOs) designed to modulate protein-RNA interactions or mRNA stability.
Modulation of mRNA spatial distribution and translation through the disruption or stabilization of RNA-protein complexes (RNPs) at specific cis-acting sequences.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoskeletal gene messenger RNA 3' untranslated regions (Cytoskeletal mRNA 3' UTRs).